They built a game-changing cancer-killing therapy. Now they’re taking on a new kind of CAR-T therapy – STAT
STAT |
They built a game-changing cancer-killing therapy. Now they're taking on a new kind of CAR–T therapy
STAT The two former Kite Pharma executives behind a game-changing cancer-killing technology 1 are launching their next act: a new company to develop a suite of so-called off-the-shelf CAR–T therapy assets, designed so that they do not need to be … Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer's Allogeneic CAR T Immuno … |
